Vince Owens, Founder and Managing General Partner of Guide Medical Ventures, has 25 years of medical device industry experience, including multiple successful exits as start-up founder and CEO.  Most recently, he was co-founder and CEO of Intelect Medical, a deep brain stimulation technology company acquired by Boston Scientific in 2011.  Mr. Owens holds a B.S. in Mechanical Engineering from Carnegie Mellon university and an MBA.  Mr. Owens serves on the boards of several privately held medical device companies.


Brock Tice began his work on CardioSolv's technology in 2006 and has extensive experience in research and development of the company's patient-specific modeling and VT ablation guidance system.  Dr. Tice received his PhD degree in Biomedical Engineering from Johns Hopkins University in 2009.  Dr. Tice's doctoral research involved the creation and use of high-resolution computational models of the heart, with both structural and electrophysiological heterogeneities, and produced mechanistic insight into the initiation, sustenance, and termination of re-entrant arrhythmias.


Scott Kokones, Founder and General Partner of Guide Medical Ventures, was cofounder and Sr. VP of R&D for Intelect Medical through successful exit in 2011.  Prior to joining Intelect, Mr. Kokones held various R&D engineering and leadership roles at Medtronic and Enpath Medical, where he worked on implantable devices for SCS, CRDM, and DBS.  He holds a B.S. in Mechanical Engineering from the University of Michigan and an MBA from Boston University.  Mr. Kokones currently serves on the boards of several privately held companies.


Mr. Steve R. LaPorte is a Venture Partner of Onset Ventures. Mr. LaPorte joined Onset Ventures on November 9, 2005. Mr. LaPorte focuses on medical technology, which includes early stage investments in neuromodulation or the use of electricity in medical devices to stimulate the nervous system. He has 27 years of experience in the medical device industry and spent the past 17 years as an executive at Medtronic. From 2002 until his retirement in August 2005, Mr. LaPorte served as the Vice President at NeuroVentures and Business Development at Medtronic. Prior to this, from 2000 to 2002, he served as a Vice President and General Manager at Medtronic's Drug Delivery Division; from 1994 to 2000, he held the position of a Vice President and General Manager of Medtronic's Electrophysiology Systems Division; and from 1988 to 1994 he was the Vice President of Operations for Medtronic's Neurological Division. Mr. LaPorte began his career at Medtronic in 1978. He has been Independent Director of AngioDynamics Inc., since January 29, 2007. He has been a Director of Rita Medical Systems Inc. since October 5, 2005. He serves as Director of Valeritas, Inc. Mr. LaPorte holds an M.B.A. from the University of Minnesota and a B.S. in Mathematics and Computer Science from the University of Wisconsin Stevens Point.


Steve Girouard was most recently President & CEO of Securus Medical, Inc (acquired by Boston Scientific). Prior to Securus he was Vice President of Emerging Technologies in the Corporate Office of Science and Technology at Johnson & Johnson. Earlier in his career he was a Partner at Omega Funds and Oakwood Medical Investors, and he was the founding Executive Director of the Cleveland Clinic Atrial Fibrillation Innovation Center, a center created for the development of novel technologies for the treatment of arrhythmias. He started his career at Guidant Corporation where he held various technology management positions. He holds over 35 United States and international patents and has authored numerous peer-reviewed articles and book chapters in the field of electrophysiology. Dr. Girouard earned his B.S. degree in Biomedical Engineering from Boston University and his Master’s and Doctoral degrees in Biomedical Engineering from Case Western Reserve University.

© 2019 CardioSolv Inc.